红光疗法用于血栓形成和血液静止
Bingwen Eugene Fan1,2,3,4, Leonardo Pasalic5,6, Yu Yue Hew1
1Department of Haematology, Tan Tock Seng Hospital, Singapore.
Seminars in thrombosis and hemostasis
|October 8, 2025
概括
红光疗法显示,通过影响关键的生物通路,有望控制血栓形成和血静. 需要进一步的研究来优化方案,并确认其临床疗效,特别是在高风险患者.
科学领域:
- 生物医学工程 生物医学工程
- 血液学 血液学 血液学
- 照相医疗 (photomedicine) 是一种医学.
背景情况:
- 红光疗法 (光生物调节) 正在研究其对血栓形成和血液静止的非药物效应.
- 它影响氧化释放,内皮功能,血小板激活和血管律,解决维尔霍夫三位一体的组成部分.
- 潜在的益处包括减少血小板聚合和改善微血管输液,抵消血栓炎症.
研究的目的:
- 探索红光疗法的潜力,作为调节血栓和血液静止的非药物治疗方法.
- 审查光生物调节可能影响导致凝块形成的因素的机制.
- 确定临床实施的挑战和未来研究方向.
主要方法:
- 关于光生物调节 (红色,NIR,FIR波长) 以及其对静血和血栓路径的影响的实验数据和现有文献的审查.
- 分析这些效应如何与Virchow的三位一体和血栓炎症有关.
- 考虑诸如组织透和协议标准化等限制.
主要成果:
- 光生物调节影响内皮功能,血小板活动和血管度,可能减少血小板聚合并改善输液.
- 观察到的好处可能与直接红/红外线效应或排除蓝光有关.
- 挑战包括标准化,组织透和从实验模型的翻译.
结论:
- 红光疗法为血栓形成管理提供了一个有前途的途径,特别是在常规抗凝药的高出血风险患者中.
- 进一步的研究是必不可少的,以确定最佳参数,阐明机制,并通过随机临床试验验证实疗效.
- 确定其在血栓形成管理中的作用需要对剂量,途径和临床结果进行严格的调查.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.7K
01:24Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
01:05Introduction to Hemostasis
12.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.9K
01:30Venous Thrombosis IV: Nursing Management
175
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
175